HighTower and other investors increase Gilead holdings as dividend is set
HighTower Advisors added 84,450 shares of Gilead Sciences, while State Street and Bank of America also increased positions during the quarter. Gilead disclosed a quarterly dividend to be paid Sept. 29, with a currently negative payout ratio of -122.85%. Maxim raised its rating to buy and set a $165 price target, as analysts forecast -0.48 EPS for the year.